Stepping away from the agency you built takes careful thought and precise timing. You have dedicated your career to providing compassionate end-of-life care, and now as you look toward the future, you want to ensure your business transitions smoothly while rewarding your hard work.

The 2026 market presents a unique window of opportunity for owners. Buyers are actively seeking high-quality assets, but their scrutiny has never been more intense. They are looking closely at specific financial and operational metrics to determine true equity value. If you are selling a healthcare business this year, understanding these metrics is your biggest advantage.

To secure the best possible multiple, you must view your agency through the eyes of an acquirer. This means a deep understanding of how your operational performance and regulatory and/or CAP related issues will impact your final purchase price.

Here is what you need to know to prepare your agency for a lucrative and successful exit.

The 2026 Market for Hospice Acquisitions

The demand for post-acute care continues to rise alongside an aging population. Institutional capital, private equity firms, and strategic buyers are heavily invested in this space. They view hospice care as a stable, necessary service that offers predictable revenue streams when managed correctly.

However, the days of buyers paying premium multiples for average agencies are behind us. The home health mergers and acquisitions market is now highly disciplined. Acquirers want sustainable margins and clean compliance records. They are digging deep into clinical documentation, billing practices, and staff retention rates.

When listing a hospice business for sale, your preparation dictates your leverage. Mid- to large-sized agencies that proactively manage their risks, streamline their operations, and demonstrate a profitable bottom line typically attract multiple competitive bids. Those with weak bottom lines, messy financials, or looming regulatory issues often face little demand, steep discounts, or even broken deals.

Understanding the Operational Metrics/CAP

One of the most critical factors a buyer will evaluate is your Medicare aggregate cap (CAP) status. Medicare implemented the CAP to limit the total amount of reimbursement a hospice agency can receive for patient care in a given year. If your agency exceeds this limit, you must refund the excess amount to the Centers for Medicare & Medicaid Services (CMS).

Why Buyers Fear CAP Liabilities

Buyers view CAP liabilities as a massive financial risk. If your agency is currently over the CAP, or even trending close to it, this will raise a red flag. They will not inherit this exposure, or the potential risk of increased governmental scrutiny.

Even if you have never exceeded your limit, buyers will analyze your historical data to predict current and future risk. They will look closely at your admission practices and length of stay metrics, and if there is any concern a buyer often will renegotiate the valuation and other terms, or simply walk away from the deal.

How to Mitigate CAP Concerns

To protect buyer interest in your agency and your valuation, you must demonstrate proactive CAP management. Track your CAP status on an ongoing basis, not just at the end of the reporting year. Maintain a balanced census that includes both short-term and long-term patients.

If you are currently facing a CAP liability, address it before going to market by working with a seasoned professional or advisor. Transparency is essential here. Disclosing a managed liability is far better than a buyer discovering an unmanaged one during due diligence.

Average Length of Stay (ALOS)

Your Average Length of Stay is a delicate balancing act. A very short ALOS often indicates that patients are being admitted too late in their disease process, which can harm profitability due to high upfront admission costs.

Conversely, a very long ALOS raises immediate red flags regarding CAP limits and compliance audits. Buyers want to see an ALOS that aligns with national and regional averages. This demonstrates that you admit appropriate patients and follow standard clinical guidelines.

Average Daily Census (ADC)

Size matters in healthcare M&A; your Average Daily Census directly impacts your economies of scale. Agencies with a higher ADC per location can spread fixed administrative and overhead costs across more patients, resulting in better EBITDA margins.

Buyers look for consistent, sustainable census growth. Spikes and sharp drops in your ADC suggest an unstable referral network. Focus on building deep, lasting relationships with local hospitals, skilled nursing facilities, and other referral sources to stabilize your census before a sale.

Staffing Stability and Retention

The ongoing nursing shortage makes clinical staff one of your most valuable assets. High turnover rates can disrupt patient care, increase recruitment costs, and scare away potential buyers.

Acquirers want to buy a fully functioning team, not an empty roster. Document your retention strategies, compensation packages, and workplace culture initiatives. Agencies with tenured clinical directors and loyal nursing staff always command stronger interest.

Clinical Compliance and Chart Audits

Regulatory compliance is the ultimate dealmaker or deal-breaker. Buyers will conduct rigorous mock audits during due diligence. They will pull patient charts to verify terminal prognoses, physician narratives, and face-to-face encounter documentation.

A history of clean surveys and robust internal compliance programs gives buyers peace of mind. Conduct your own internal audits before engaging a buyer. Identify missing signatures or weak documentation and correct the underlying processes immediately.

Core Valuation Driver for Hospice Agencies

Beyond operational metrics and CAP status, size will determine your multiple while profitability or AEBITDA will guide your final valuation. While buyers will likely pay premiums for agencies that demonstrate efficiency, compliance, and clinical excellence, in the end, overall size is the main factor that dictates multiples and drives valuation.

Preparing Your Agency for the Market

Selling a hospice agency takes time, strategy, and expert guidance. The most successful exits require deliberate preparation.

Start by recasting your financials. Work with an advisor to identify add-backs and calculate your true Adjusted EBITDA. Clean up your accounts receivable by writing off uncollectible debt and standardizing your billing processes.

At the same time, collect and organize your legal and operational documents. This includes all licenses, payer contracts, lease agreements, and employee handbooks. Having this information readily available speeds up the process and signals professionalism to serious buyers.

Finally, keep your operations running smoothly. It is easy to get distracted by the sale process and let your patient census drop, but a decline in revenue during negotiations gives the buyer leverage to lower their purchase price. Maintain your focus on exceptional patient care all the way to the end.

Secure Your Legacy and Your Financial Future

Navigating the complexities of CAP limits and EBITDA multiples requires specialized knowledge. You get one chance to sell the business you spent years building; do not leave money on the table by entering the market unprepared.

At Stoneridge Partners, we specialize exclusively in healthcare M&A. We understand the specific nuances of the 2026 hospice market and know exactly how to position your agency for maximum value. Our team will guide you through every step of the process, from initial valuation to the final closing.

If you are ready to explore your options, contact Stoneridge Partners today for a confidential strategy consultation. Let us help you secure the exit you deserve.